ESC 365 - Enabling and optimizing RAASi therapy in cardio-renal patients by controlling potassium level.

HFA Premium Access

Enabling and optimizing RAASi therapy in cardio-renal patients by controlling potassium level.

Session: Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels

Topic: Miscellaneous

Speaker: Professor B. Pitt (Ann Arbor, US)

Sponsored by Vifor Pharma/Vifor Fresenius Medical Care Renal Pharma

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Professor Bertram Pitt

University of Michigan, Ann Arbor (United States of America)

24 presentations

0 follower

1 more presentation in this session

Enabling and optimizing RAASi therapy in cardio-renal patients by controlling potassium levels.

Speaker: Professor M. Boehm (Homburg, DE) Professor C. Lam (Singapore, SG)

Access the full session

Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels

Speakers: Professor B. Pitt, Professor M. Boehm, Professor C. Lam

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources